BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16081513)

  • 1. Antitumor effect of parathyroid hormone-related protein neutralizing antibody in human renal cell carcinoma in vitro and in vivo.
    Talon I; Lindner V; Sourbier C; Schordan E; Rothhut S; Barthelmebs M; Lang H; Helwig JJ; Massfelder T
    Carcinogenesis; 2006 Jan; 27(1):73-83. PubMed ID: 16081513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
    Dougherty KM; Blomme EA; Koh AJ; Henderson JE; Pienta KJ; Rosol TJ; McCauley LK
    Cancer Res; 1999 Dec; 59(23):6015-22. PubMed ID: 10606251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectopic expression of von Hippel-Lindau tumor suppressor induces apoptosis in 786-O renal cell carcinoma cells and regresses tumor growth of 786-O cells in nude mouse.
    Kim M; Yan Y; Lee K; Sgagias M; Cowan KH
    Biochem Biophys Res Commun; 2004 Jul; 320(3):945-50. PubMed ID: 15240140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.
    Agouni A; Sourbier C; Danilin S; Rothhut S; Lindner V; Jacqmin D; Helwig JJ; Lang H; Massfelder T
    Carcinogenesis; 2007 Sep; 28(9):1893-901. PubMed ID: 17468516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone-related protein in human renal cell carcinoma.
    Sourbier C; Massfelder T
    Cancer Lett; 2006 Aug; 240(2):170-82. PubMed ID: 16223565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.
    Danilin S; Sourbier C; Thomas L; Rothhut S; Lindner V; Helwig JJ; Jacqmin D; Lang H; Massfelder T
    Carcinogenesis; 2009 Mar; 30(3):387-96. PubMed ID: 19056930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H; Tsunenari T; Onuma E; Sato K; Ogata E; Yamada-Okabe H
    Anticancer Res; 2005; 25(6B):3817-23. PubMed ID: 16309168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
    Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
    J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoids.
    Iwai A; Fujii Y; Kawakami S; Takazawa R; Kageyama Y; Yoshida MA; Kihara K
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):11-7. PubMed ID: 15489000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy of experimental renal cell carcinoma with a novel conjugate of monoclonal antibody 138H11 and calicheamicin thetaI1.
    Knoll K; Wrasidlo W; Scherberich JE; Gaedicke G; Fischer P
    Cancer Res; 2000 Nov; 60(21):6089-94. PubMed ID: 11085532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.
    Sourbier C; Danilin S; Lindner V; Steger J; Rothhut S; Meyer N; Jacqmin D; Helwig JJ; Lang H; Massfelder T
    Cancer Res; 2007 Dec; 67(24):11668-76. PubMed ID: 18089796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer.
    Montgrain PR; Quintana R; Rascon Y; Burton DW; Deftos LJ; Casillas A; Hastings RH
    Cancer; 2007 Sep; 110(6):1313-20. PubMed ID: 17676588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of an imidazoquinoline in renal cell carcinoma.
    Schwartz MJ; Liu H; Hwang DH; Kawamoto H; Scherr DS
    Urology; 2009 May; 73(5):1156-62. PubMed ID: 19118885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
    Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
    Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p53 in renal carcinoma cells is independent of pVHL.
    Stickle NH; Cheng LS; Watson IR; Alon N; Malkin D; Irwin MS; Ohh M
    Mutat Res; 2005 Oct; 578(1-2):23-32. PubMed ID: 15998523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice.
    Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ
    Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A murine vascular endothelial growth factor antibody inhibits in vivo growth of human Caki-I renal adenocarcinoma.
    Dagnaes-Hansen F; Rasmussen LM; Tilton R; Denner L; Flyvbjerg A
    Anticancer Res; 2003; 23(2B):1625-30. PubMed ID: 12820432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.